OR Elpen It takes part in important and recognized international exhibitions over time, focusing on strengthening its international presence. In this context, he participated in the Berma International Exhibition, the largest exhibition in the wider Latin American region at B2B level.
The event took place in Mexico between March 31 with April 1, 2025. During its conduct, ELPEN executives held meetings with local companies discussing the company’s activity and the specifications required for the penetration of its medicines.
Extraversion is an essential component in Elpen’s philosophy. Its export activities start in the 1990s and its preparations are now exported to more than 90 countries worldwide. In the last two years, the company has gone 200% in sales from markets outside Greece.
In addition, since 2012 it has Elpen Pharma GmbH, a subsidiary in Germany, a country in which it has been experiencing significant recognition for years for the quality of the drugs bearing its signature. In 2024, Elpen opened its wings to one of the rapidly growing healthcare markets, setting up a subsidiary in the United Arab Emirates and specifically in Dubai.
This year’s Be Pharma involved 166 companies with representatives from Central America to Chile. It is noteworthy that in addition to the major pharmaceutical companies operating in Mexico, this event attracts the interest of more and more international companies.